SCHEMBL7309325

SCHEMBL7309325

CCOC(=O)N(CCCCCl)c1cccc(F)c1C(=O)OC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.38
TP53 P04637 2/20 0.38
NLRP3 Q96P20 1/20 0.37
SMN1; SMN2 Q16637 4/20 0.36
HPGD P15428 2/20 0.35
RAB9A P51151 4/20 0.34
NPC1 O15118 3/20 0.34
KDM4E B2RXH2 2/20 0.34
GPX4 P36969 1/20 0.34
PAX8 Q06710 1/20 0.34
GLA P06280 1/20 0.34
GAA P10253 1/20 0.34
TSHR P16473 1/20 0.34
HSD17B10 Q99714 1/20 0.34
KMT2A Q03164 1/20 0.34
BDKRB1 P46663 2/20 0.34
CYP1A2 P05177 1/20 0.33
CYP2C19 P33261 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7302910 0.89 TP53 (0.44) ALDH1A1TP53NLRP3SMN1; SMN2HPGD
SCHEMBL9432839 0.88 ALDH1A1 (0.39) ALDH1A1TP53NLRP3SMN1; SMN2HPGD
SCHEMBL7309288 0.87 TSHR (0.40) ALDH1A1TP53SMN1; SMN2RAB9ANPC1
SCHEMBL7295840 0.83 ALDH1A1 (0.38) ALDH1A1TP53SMN1; SMN2HPGDRAB9A
SCHEMBL3534417 0.78 NLRP3 (0.38) ALDH1A1NLRP3SMN1; SMN2RAB9ANPC1
SCHEMBL7302447 0.76 PARP1 (0.42) ALDH1A1KDM4E
SCHEMBL7303328 0.75 NR4A2 (0.39) ALDH1A1TP53NLRP3SMN1; SMN2HPGD
SCHEMBL7298470 0.73 ALDH1A1 (0.40) ALDH1A1TP53SMN1; SMN2HPGDRAB9A
SCHEMBL7299287 0.73 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2HPGDRAB9ANPC1
SCHEMBL7298114 0.73 SMN1; SMN2 (0.41) ALDH1A1SMN1; SMN2HPGDKDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5304560-A Treating CNS disorders; dopamine receptor antagonist FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-04-19 US disclosed
EP-0481342-A1 Quinazoline derivatives and their preparation FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-04-22 EP disclosed